C. Ercolani

发表

Expression of phosphorylated Hippo pathway kinases (MST1/2 and LATS1/2) in HER2-positive and triple-negative breast cancer patients treated with neoadjuvant therapy

Francesca Sperati, Ruggero De Maria, M. T. Ramieri, 2017, Cancer biology & therapy.

Association between AXL, Hippo Transducers, and Survival Outcomes in Male Breast Cancer

V. Speirs, M. Mottolese, A. Shaaban, 2017, Journal of cellular physiology.

HMG-CoAR expression in male breast cancer: relationship with hormone receptors, Hippo transducers and survival outcomes

V. Speirs, M. Mottolese, A. Shaaban, 2016, Scientific Reports.

HER2 Protein and Gene Variation between Primary and Metastatic Breast Cancer: Significance and Impact on Patient Care

M. Mottolese, F. Cognetti, A. Fabi, 2011, Clinical Cancer Research.

HER 2 change between primary and metastatic breast cancer 1 HER 2 PROTEIN AND GENE VARIATION BETWEEN PRIMARY AND METASTATIC BREAST CANCER : SIGNIFICANCE AND IMPACT ON PATIENT CARE

M. Mottolese, F. Cognetti, A. Fabi, 2011 .

Predictive Biomarkers and Personalized Medicine HER 2 Protein and Gene Variation between Primary and Metastatic Breast Cancer : Significance and Impact on Patient Care

M. Mottolese, F. Cognetti, A. Fabi, 2011 .

KRAS gene amplification in colorectal cancer and impact on response to EGFR‐targeted therapy

I. Nagtegaal, F. Nicolantonio, A. Bardelli, 2013, International journal of cancer.

Multicenter Evaluation of the Idylla GeneFusion in Non-Small-Cell Lung Cancer.

E. Schuuring, A. Rappa, B. Bellosillo, 2022, The Journal of molecular diagnostics : JMD.

Melanoma-specific bcl-2 promotes a protumoral M2-like phenotype by tumor-associated macrophages

V. Farini, A. Sica, E. Gallo, 2020, Journal for ImmunoTherapy of Cancer.

A Real-World Systematic Analysis of Driver Mutations’ Prevalence in Early- and Advanced-Stage NSCLC: Implications for Targeted Therapies in the Adjuvant Setting

G. Ciliberto, L. Landi, F. Cappuzzo, 2022, Cancers.

Body mass index modifies the relationship between γ-H2AX, a DNA damage biomarker, and pathological complete response in triple-negative breast cancer

I. Vitale, M. Mottolese, I. Terrenato, 2017, BMC Cancer.

Relationship between K-Ras mutational status and EGFR expression evaluated using Allred score in primary and metastatic colorectal cancer.

B. Casini, M. Diodoro, M. Mottolese, 2010 .

Semaphorin 5A drives melanoma progression: role of Bcl-2, miR-204 and c-Myb

D. Trisciuoglio, B. Calabretta, M. Rizzo, 2018, Journal of Experimental & Clinical Cancer Research.

HER2 change between primary and metastatic breast cancer 1 HER2 PROTEIN AND GENE VARIATION BETWEEN PRIMARY AND METASTATIC BREAST CANCER: SIGNIFICANCE AND IMPACT ON PATIENT CARE

M. Mottolese, F. Cognetti, A. Fabi, 2011 .

The Impact of the Hippo Pathway and Cell Metabolism on Pathological Complete Response in Locally Advanced Her2+ Breast Cancer: The TRISKELE Multicenter Prospective Study

N. Tinari, G. Ciliberto, F. Cappuzzo, 2022, Cancers.

Inhibition of lysine acetyltransferases impairs tumor angiogenesis acting on both endothelial and tumor cells

V. Farini, S. Carradori, D. Trisciuoglio, 2020, Journal of experimental & clinical cancer research : CR.

High expression of HLA-E in colorectal carcinoma is associated with a favorable prognosis

Elisa Lo Monaco, M. Diodoro, M. Mottolese, 2011, Journal of Translational Medicine.

Supplementary Figure 2

Valeria Panebianco, Andrea Sacconi, Laura Lorenzon, 2012 .

Body mass index modifies the relationship between γ-H2AX, a DNA damage biomarker, and pathological complete response in triple-negative breast cancer

I. Vitale, M. Mottolese, I. Terrenato, 2017, BMC Cancer.

Predictive significance of DNA damage and repair biomarkers in triple-negative breast cancer patients treated with neoadjuvant chemotherapy: An exploratory analysis

I. Vitale, M. Mottolese, A. Fabi, 2015, Oncotarget.

Analysis of the ATR-Chk1 and ATM-Chk2 pathways in male breast cancer revealed the prognostic significance of ATR expression

G. Ciliberto, V. Speirs, I. Vitale, 2017, Scientific Reports.

miR-155 drives telomere fragility in human breast cancer by targeting TRF1.

R. Agami, G. Blandino, A. Sacconi, 2014, Cancer research.

Liquid biopsy identifies actionable dynamic predictors of resistance to Trastuzumab Emtansine (T-DM1) in advanced HER2-positive breast cancer

G. Ciliberto, E. Pescarmona, F. Cognetti, 2021, Molecular cancer.

Type I IFNs promote cancer cell stemness by triggering the epigenetic regulator KDM1B

M. Helmer-Citterich, M. Biffoni, C. Galassi, 2021, Nature Immunology.

microRNA-378a-5p iS a novel positive regulator of melanoma progression

L. Fattore, R. Mancini, G. Ciliberto, 2020, Oncogenesis.

The Hippo transducers TAZ/YAP and their target CTGF in male breast cancer

V. Speirs, M. Mottolese, A. Shaaban, 2016, Oncotarget.

Topographic expression of the Hippo transducers TAZ and YAP in triple-negative breast cancer treated with neoadjuvant chemotherapy

M. Mottolese, I. Terrenato, F. Sperati, 2016, Journal of experimental & clinical cancer research : CR.

RIPK1/RIPK3 promotes vascular permeability to allow tumor cell extravasation independent of its necroptotic function

P. Muti, E. Pescarmona, G. Blandino, 2017, Cell Death & Disease.

Serum miR-22 as potential non-invasive predictor of poor clinical outcome in newly diagnosed, uniformly treated patients with diffuse large B-cell lymphoma: an explorative pilot study

G. Ciliberto, M. Marino, G. Blandino, 2018, Journal of Experimental & Clinical Cancer Research.

Breast carcinomas with low amplified/equivocal HER2 by Ish: potential supporting role of multiplex ligation-dependent probe amplification

E. Pescarmona, A. Sapino, M. Mottolese, 2017, Journal of Experimental & Clinical Cancer Research.

Gene status in HER2 equivocal breast carcinomas: impact of distinct recommendations and contribution of a polymerase chain reaction-based method.

C. Botta, G. Viale, A. Sapino, 2014, The oncologist.

Pyrvinium Pamoate Induces Death of Triple-Negative Breast Cancer Stem–Like Cells and Reduces Metastases through Effects on Lipid Anabolism

E. Ruppin, G. Ciliberto, S. Ambs, 2020, Cancer Research.

Not enough can be enough: feasibility of the Idylla EGFR mutation test when reuse of stained tissue slides is the only option available

G. Ciliberto, F. Cappuzzo, P. Visca, 2021, Journal of Clinical Pathology.

Epidermal growth factor receptor gene copy number may predict lapatinib sensitivity in HER2-positive metastatic breast cancer

M. Marino, M. Mottolese, F. Cognetti, 2013, Expert opinion on pharmacotherapy.

Decrease of survivin, p53 and Bcl-2 expression in chemorefractory colorectal liver metastases may be predictive of radiosensivity after radioembolization with yttrium-90 resin microspheres

F. Izzo, F. Fiore, M. Diodoro, 2013, Journal of experimental & clinical cancer research : CR.

External Quality Assessment (EQA) program for the preanalytical and analytical immunohistochemical determination of HER2 in breast cancer: an experience on a regional scale

A. Paradiso, A. Paradiso, M. Mottolese, 2013, Journal of Experimental & Clinical Cancer Research.

miR-204 targets Bcl-2 expression and enhances responsiveness of gastric cancer

P. Muti, E. Pescarmona, G. Blandino, 2012, Cell Death and Disease.

External Quality Assessment (EQA) program for the preanalytical and analytical immunohistochemical determination of HER2 in breast cancer: an experience on a regional scale

A. Paradiso, M. Mottolese, S. Pizzamiglio, 2013, Journal of experimental & clinical cancer research : CR.

Prognostic relevance of DNA damage and repair biomarkers in elderly patients with hormone-receptor-positive breast cancer treated with neoadjuvant hormone therapy: evidence from the real-world setting

N. Tinari, G. Ciliberto, L. Mariani, 2019, Therapeutic advances in medical oncology.

Overexpression of activated phospholipase Cγ1 is a risk factor for distant metastases in T1‐T2, N0 breast cancer patients undergoing adjuvant chemotherapy

N. Tinari, S. Iacobelli, M. Mottolese, 2013, International journal of cancer.

Serum miR-22 as potential non-invasive predictor of poor clinical outcome in newly diagnosed, uniformly treated patients with diffuse large B-cell lymphoma: an explorative pilot study

G. Ciliberto, M. Marino, G. Blandino, 2018, Journal of experimental & clinical cancer research : CR.

Breast carcinomas with low amplified/equivocal HER2 by Ish: potential supporting role of multiplex ligation-dependent probe amplification

E. Pescarmona, A. Sapino, M. Mottolese, 2017, Journal of experimental & clinical cancer research : CR.

Supplementary Figure 2

P. Deloukas, G. Marth, W. McLaren, 2014 .

Analysis of the ATR-Chk1 and ATM-Chk2 pathways in male breast cancer revealed the prognostic significance of ATR expression

G. Ciliberto, V. Speirs, I. Vitale, 2017, Scientific Reports.

p53 and BLC2 Immunohistochemical Expression Across Molecular Subtypes in 1099 Early Breast Cancer Patients With Long-Term Follow-up: An Observational Study.

E. Pescarmona, M. Mottolese, F. Cognetti, 2020, Clinical breast cancer.

Unusual phylogenetic tree and circulating actionable ESR1 mutations in an aggressive luminal/HER2-low breast cancer: Case report

G. Ciliberto, A. Fabi, P. Giacomini, 2023, Frontiers in Oncology.

Topographic expression of the Hippo transducers TAZ and YAP in triple-negative breast cancer treated with neoadjuvant chemotherapy

M. Mottolese, I. Terrenato, F. Sperati, 2016, Journal of Experimental & Clinical Cancer Research.